ENSG Quote, Financials, Valuation and Earnings

Guardian Pharmacy Services has a net margin of 7.25% compared to Ensign Group's net margin of -38.8%. Ensign Group's return on equity of 15.07% beat Guardian Pharmacy Services's return on equity of -109.2%.

Ensign Group has a consensus price target of $169.50, signalling upside risk potential of 27.93%. On the other hand Guardian Pharmacy Services has an analysts' consensus of -- which suggests that it could grow by 21.27%. Given that Ensign Group has higher upside potential than Guardian Pharmacy Services, analysts believe Ensign Group is more attractive than Guardian Pharmacy Services.

Ensign Group has a beta of 0.935, which suggesting that the stock is 6.508% less volatile than S&P 500. In comparison Guardian Pharmacy Services has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. Guardian Pharmacy Services offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 6.16% of its earnings as a dividend. Guardian Pharmacy Services pays out 160.75% of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Guardian Pharmacy Services's is not.

Ensign Group quarterly revenues are $1.1B, which are larger than Guardian Pharmacy Services quarterly revenues of $314.4M. Ensign Group's net income of $78.4M is higher than Guardian Pharmacy Services's net income of -$122M. Notably, Ensign Group's price-to-earnings ratio is 32.16x while Guardian Pharmacy Services's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.87x versus 1.04x for Guardian Pharmacy Services. Usually stocks with elevated PS ratios are considered overvalued.

LifeStance Health Group has a net margin of 7.25% compared to Ensign Group's net margin of -1.91%. Ensign Group's return on equity of 15.07% beat LifeStance Health Group's return on equity of -6.64%.

Ensign Group has a consensus price target of $169.50, signalling upside risk potential of 27.93%. On the other hand LifeStance Health Group has an analysts' consensus of $8.70 which suggests that it could grow by 10.97%. Given that Ensign Group has higher upside potential than LifeStance Health Group, analysts believe Ensign Group is more attractive than LifeStance Health Group.

Ensign Group has a beta of 0.935, which suggesting that the stock is 6.508% less volatile than S&P 500. In comparison LifeStance Health Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. LifeStance Health Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 6.16% of its earnings as a dividend. LifeStance Health Group pays out -- of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ensign Group quarterly revenues are $1.1B, which are larger than LifeStance Health Group quarterly revenues of $312.7M. Ensign Group's net income of $78.4M is higher than LifeStance Health Group's net income of -$6M. Notably, Ensign Group's price-to-earnings ratio is 32.16x while LifeStance Health Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.87x versus 2.45x for LifeStance Health Group. Usually stocks with elevated PS ratios are considered overvalued.

PACS Group has a net margin of 7.25% compared to Ensign Group's net margin of -1.11%. Ensign Group's return on equity of 15.07% beat PACS Group's return on equity of --.

Ensign Group has a consensus price target of $169.50, signalling upside risk potential of 27.93%. On the other hand PACS Group has an analysts' consensus of $34.83 which suggests that it could grow by 160.92%. Given that PACS Group has higher upside potential than Ensign Group, analysts believe PACS Group is more attractive than Ensign Group.

Ensign Group has a beta of 0.935, which suggesting that the stock is 6.508% less volatile than S&P 500. In comparison PACS Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. PACS Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 6.16% of its earnings as a dividend. PACS Group pays out 71.23% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Ensign Group quarterly revenues are $1.1B, which are larger than PACS Group quarterly revenues of $981.8M. Ensign Group's net income of $78.4M is higher than PACS Group's net income of -$10.9M. Notably, Ensign Group's price-to-earnings ratio is 32.16x while PACS Group's PE ratio is 20.01x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.87x versus 0.59x for PACS Group. Usually stocks with elevated PS ratios are considered overvalued.

Pennant Group has a net margin of 7.25% compared to Ensign Group's net margin of 3.43%. Ensign Group's return on equity of 15.07% beat Pennant Group's return on equity of 13.06%.

Ensign Group has a consensus price target of $169.50, signalling upside risk potential of 27.93%. On the other hand Pennant Group has an analysts' consensus of $38.25 which suggests that it could grow by 40.17%. Given that Pennant Group has higher upside potential than Ensign Group, analysts believe Pennant Group is more attractive than Ensign Group.

Ensign Group has a beta of 0.935, which suggesting that the stock is 6.508% less volatile than S&P 500. In comparison Pennant Group has a beta of 1.935, suggesting its more volatile than the S&P 500 by 93.465%.

Ensign Group has a quarterly dividend of $0.06 per share corresponding to a yield of 0.18%. Pennant Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Ensign Group pays 6.16% of its earnings as a dividend. Pennant Group pays out -- of its earnings as a dividend. Ensign Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Ensign Group quarterly revenues are $1.1B, which are larger than Pennant Group quarterly revenues of $180.7M. Ensign Group's net income of $78.4M is higher than Pennant Group's net income of $6.2M. Notably, Ensign Group's price-to-earnings ratio is 32.16x while Pennant Group's PE ratio is 39.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Ensign Group is 1.87x versus 1.25x for Pennant Group. Usually stocks with elevated PS ratios are considered overvalued.